Phase II Trial of Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC)
Summary
The purpose of this phase II study is to learn if Niraparib can help to control metastatic pancreatic cancer. The safety of this drug will also be studied.
General Information
NCT#: NCT03553004
Study ID: IIT-2017-NIRA-PANC
Trial Phase: Phase II
Trial Sponsor: University of Kansas Medical Center, Tesaro
Therapies Used in This Trial: Niraparib